Back to search

Article

The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of Acute Myeloid Leukemias

2021-03-04

Abstract excerpt

Resistance to chemotherapeutic drugs is a major cause of treatment failure in Acute Myeloid Leukemias (AML). To better characterize the mechanisms of chemoresistance, we first identified genes whose expression is dysregulated in AML cells resistant to daunorubicin (DNR) or cytarabine (Ara-C), the main drugs used for the induction therapy. The genes found activated are mostly linked to immune signaling and inflamma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
817d6bc5-5438-5822-9c66-815d0f424f52
DOI
10.1101/2021.03.04.433871
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of Acute Myeloid LeukemiasDOI 10.1101/2021.03.04.433871
Select a neighboring publication to make it the new centre.